FDA adcomm raises questions on effectiveness of Grail's cancer test

Members of the FDA's Molecular and Clinical Genetics Panel and FDA officials on Wednesday raised questions about Grail's next-generation sequencing test for the early detection of multiple types of cancer in adults over 50. The ...